2Stroke prevention in atrial fibrillation investigators. Stroke prevention in atria/fibrllation study finaI resuIts [ J ]. Circulation, 1991,84(2) :527 -539.
3The Bosten Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low - dose warfarin on the risk of stroke in patients with nonrheumatic atriaI fibrillation [ J]. N Engl J Med,1990,323 (22) :1505 -1511.
4Stroke prevention in atrial fibrillation investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation:the stroke prevention in atrial fibrilIation study [ J ]. J Stroke Cerebrovasc Dis, 1995,5 (9) : 147 - 157.
5Aboaf Ap, Wolf PS. Paroxysmal atrial fibrillation: A common but neglected entity [ J ]. Arch Intern Med, 1996,156 (5) :362 - 367.
6Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibfillation : a report of the American college of cardioIogy/Ametican heart association task force on practice guidelines and the European society of cardiology committee for practice guideIines and policy conferences( committee to develop guidelines for the management of patients with atrial fibrillation )deveIoped in colleboration with the North American Society of Pacing and EIectrophysioIogy[ J]. Eur Heart J,2001,22(2) :1852 -1923.
7Laupaeis A, AIbers G, Dalen J, et al. Antithrombotic therapy in atrial fibrilllation [ J ]. Chest. 1995,108 (4) :352 - 359.
8The European Atria/Fibrillation Trial Study Group. Optima/oral anticoagulant therapy in patients with nonrheumatic atria/fibrillation and recent cerebral ischemia[J]. N Engl J Med, 1995,333 (1) :5-10.
9Bjerkelunt C J, Oring OM. Electric cardioversion with arhicoagufation therapy[ J ]. Am. J Cardiof, 1996,23 (7) :208-216.
10Laupacis A, Alber G. Antithrombotic therapy in atrial fibrillation [J]. Chest,1995,104(4) :352s-359s.
